채용
岗位职责:
- 参与协助制定公司发展战略和发展规划;
- 组织和实施公司的战略规划和生产计划,确保制剂生产任务保质保量完成;
- 根据公司计划制定本制剂生产计划和部门预算;
- 负责制剂团队的搭建及梯度建设,绩效合同签订及考核;
- 按照公司质量体系要求,强化并监督本部门员工的质量意识和风险意识,检查和回顾生产体系的运行情况,不断提升员工的意识;
- 保障车间安全生产符合公司EHS要求,掌握生产车间的质量状态,沟通协调业务相关部门,解决生产过程中存在的问题;
- 组织和协调生产车间新产品、新技术、新设备的引进;
- 协助质量部门完成NMPA、FDA等外部审计部门或合作单位的审计,并根据审计整改项执行整改及反馈;
- 负责制剂区域工作相关风险的识别与管理,按照GMP要求与公司内部流程,领导或参与偏差调查,偏差控制,CAPA的执行跟踪,自检等;
- 负责制剂CDMO项目的管理,包括但不限于CDMO供应商的选择、考察、生产安排、生产过程管理、过程问题协调处理及最终产品的交付。
任职要求:
- 本科本科及以上学历,药学、化学、化工、制药工程或相关专业。
- 必需具备15年以上制药行业制剂生产经验,其中至少5年是在商业化生产环境中担任生产经理或以上职位。
- 熟悉生物大分子药物生产相关理论知识,拥有丰富的、大规模的无菌制剂/液体制剂商业化生产管理经验,深刻理解规模化生产的挑战与解决方案。
- 具备成功应对国内外药监部门(如NMPA, FDA)GMP审计的实战经验
- 熟悉制剂相关的设备、生产工艺等理论知识;
- 具备良好的沟通协调能力、领导力、团队协作能力及抗压能力;
- 具备良好的职业素养;
- 具备较强的监督、自我管理、执行力;
- 英文可作为工作语言。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고
BioNTech 소개

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
4d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
1w ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
1w ago



